Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching

Objective: Thymosin alpha 1 (Thymosin-α1) is a potential treatment for patients with COVID-19. We aimed to determine the effect of Thymosin-α1 in non-severe patients with COVID-19. Methods: We retrospectively enrolled 1,388 non-severe patients with COVID-19. The primary and secondary clinical outcom...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Med (Lausanne)
मुख्य लेखकों: Huang, ChenLu, Fei, Ling, Xu, Wei, Li, WeiXia, Xie, XuDong, Li, Qiang, Chen, Liang
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2021
विषय:
Medicine
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102900/
https://ncbi.nlm.nih.gov/pubmed/33968969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.664776
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन